Can viral infections cause severe neutropenia (absolute neutrophil count (ANC) < 0.9)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Viral Infections Cause Severe Neutropenia (ANC <0.9)?

Yes, viral infections can cause neutropenia with ANC <0.9, though this is relatively uncommon and typically occurs with specific viral pathogens, particularly in immunocompromised hosts.

Epidemiology and Severity

Viral infections are a recognized cause of neutropenia, but the severity is typically mild to moderate rather than severe:

  • Influenza infections cause neutropenia in approximately 15% of hospitalized patients, but the majority remain mild with ANC >1.0 × 10⁹/L 1
  • Only a small subset of viral infections progress to severe neutropenia (ANC <0.5 × 10⁹/L or <0.9 × 10⁹/L) 1
  • Neutropenia from viral infections is dose-dependently associated with viral disease severity, with odds ratios of 2.32 for subnormal counts, 2.80 for mild neutropenia, and 4.77 for moderate-severe neutropenia 2

High-Risk Viral Pathogens

Certain viruses are more likely to cause clinically significant neutropenia:

  • HIV is strongly associated with neutropenia through direct bone marrow suppression and indirect mechanisms 2, 3
  • HIV-related neutropenia increases bacterial infection risk significantly when ANC falls below 0.75 × 10⁹/L, with the highest risk when ANC <0.5 × 10⁹/L 4
  • Cytomegalovirus (CMV) can infiltrate bone marrow and cause myelosuppression 3
  • Herpes simplex virus (HSV) and varicella-zoster virus (VZV) are recognized causes in immunocompromised patients 5
  • Epstein-Barr virus (EBV) can cause neutropenia, particularly in post-transplant settings 6
  • Influenza B causes neutropenia more frequently than influenza A (18.3% vs 10.3%) 1

Clinical Context and Mechanisms

The relationship between viral infections and neutropenia depends heavily on the clinical setting:

  • Viral infections predominantly cause neutropenia in immunocompromised patients rather than immunocompetent hosts 5
  • In neutropenic cancer patients receiving chemotherapy, viral pathogens including HSV and respiratory viruses can cause febrile episodes 7
  • Viral infections are more commonly associated with defects in cellular immunity than with isolated neutropenia 5
  • The mechanism involves direct bone marrow suppression, cytokine-mediated effects, and in some cases direct marrow infiltration 3

Important Clinical Caveats

When evaluating neutropenia with ANC <0.9, consider that:

  • Chemotherapy remains the most common cause of severe neutropenia, not viral infections 7, 8, 9
  • Viral-induced neutropenia is typically transient and self-limited in immunocompetent patients 1
  • Severe or prolonged neutropenia (>10 days) should prompt investigation for alternative causes including hematologic malignancies, which have odds ratios of 3.23-46.03 depending on neutropenia severity 2
  • Drug-induced neutropenia from antivirals (ganciclovir, foscarnet, zidovudine) can compound viral infection effects 3

Management Implications

When viral infection causes ANC <0.9:

  • Antibacterial or antifungal prophylaxis should be considered when ANC <0.5 × 10⁹/L or if febrile neutropenia is prolonged 6
  • Antiviral prophylaxis with acyclovir or valacyclovir is recommended for HSV and VZV in high-risk patients 6
  • Monitor for CMV reactivation using DNA copies if infection risk is suspected 6
  • Colony-stimulating factors are recommended for documented Grade 3 or higher neutropenia 6
  • Most viral-induced neutropenia does not require specific investigation unless severe (ANC <0.5 × 10⁹/L) or prolonged beyond expected viral illness duration 1

References

Research

Etiology of neutropenia in HIV-infected patients.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999

Research

Viral infections in neutropenia--current problems and chemotherapeutic control.

The Journal of antimicrobial chemotherapy, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neutropenia and Infection Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neutropenia Causes and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Severe Neutropenia Causes and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.